BTOG 2020 | Concurrent immunotherapy in SCLC

Kenneth O'Byrne

Kenneth O’Byrne, MD, MB, BCh, BAO, Princess Alexandra Hospital & Queensland University of Technology, Woolloongabba, Australia, discusses trials investigating atezolizumab and durvalumab in the concurrent treatment of small cell lung cancer. This interview took place at the 18th British Thoracic Oncology Group (BTOG) 2020 congress held in Dublin, UK.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter